A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds industry ...

Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...

The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...

INDIANAPOLIS — Eli Lilly and ... about drugs being sold. Lilly claims Premier Weight Loss is selling altered versions of Lilly's weight loss drugs Zepbound and Mounjaro. In the lawsuit, Lilly ...

According to a lawsuit filed by Eli Lilly on Monday ... Tirzepatide is the ingredient behind Lilly's major obesity and diabetes franchise Zepbound and Mounjaro and works as a long-acting GIP ...

Eli Lilly is grabbing headlines thanks to medicines like Mounjaro for diabetes and Zepbound for weight management. However, these therapies will run out of patent protection and stop being growth ...